Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Immunovant, Inc. (IMVT)
since 2019 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Immunovant, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1764013.
Total stock buying since 2019: $435,551,786.
Total stock sales since 2019: $25,633,620.
Total stock option exercises since 2019: $0.
Table 3. Detailed insider trading at Immunovant, Inc. (IMVT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-07-23 | Geffner Michael (Chief Medical Officer) | Sale | 2,385 | 18.15 | 43,287 |
| 2025-07-23 | Stout Jay S (Chief Technology Officer) | Sale | 2,805 | 18.15 | 50,910 |
| 2025-07-09 | Geffner Michael (Chief Medical Officer) | Sale | 1,160 | 17.24 | 19,998 |
| 2025-07-09 | Stout Jay S (Chief Technology Officer) | Sale | 1,519 | 17.24 | 26,187 |
| 2025-04-23 | Geffner Michael (Chief Medical Officer) | Sale | 2,349 | 14.79 | 34,741 |
| 2025-04-23 | Stout Jay S (Chief Technology Officer) | Sale | 1,925 | 14.79 | 28,470 |
| 2025-04-16 | Barnett Eva Renee (Chief Financial Officer) | Sale | 2,993 | 14.89 | 44,565 |
| 2025-04-16 | Salzmann Peter (Chief Executive Officer) | Sale | 8,321 | 14.89 | 123,899 |
| 2025-04-09 | Salzmann Peter (Chief Executive Officer) | Sale | 28,094 | 12.99 | 364,941 |
| 2025-03-07 | Fromkin Andrew J. (Director) | Sale | 8,000 | 19.74 | 157,920 |
| 2025-02-19 | Barnett Eva Renee (Chief Financial Officer) | Sale | 2,814 | 20.86 | 58,700 |
| 2025-02-19 | Macias William L. (Chief Medical Officer) | Sale | 2,055 | 20.86 | 42,867 |
| 2025-02-19 | Salzmann Peter (Chief Executive Officer) | Sale | 15,439 | 20.86 | 322,057 |
| 2025-01-22 | Geffner Michael (Chief Medical Officer) | Sale | 2,657 | 23.59 | 62,678 |
| 2025-01-22 | Stout Jay S (Chief Technology Officer) | Sale | 2,195 | 23.59 | 51,780 |
| 2025-01-15 | Barnett Eva Renee (Chief Financial Officer) | Sale | 2,298 | 24.00 | 55,152 |
| 2025-01-15 | Macias William L. (Chief Medical Officer) | Sale | 2,383 | 24.00 | 57,192 |
| 2025-01-15 | Salzmann Peter (Chief Executive Officer) | Sale | 8,767 | 24.00 | 210,408 |
| 2025-01-13 | Roivant Sciences Ltd. | Buy | 16,845,010 | 20.00 | 336,900,200 |
| 2025-01-08 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,105 | 24.10 | 98,930 |
| 2025-01-08 | Salzmann Peter (Chief Executive Officer) | Sale | 5,105 | 24.10 | 123,030 |
| 2024-12-02 | Hughes Douglas J. (Director) | Sale | 5,425 | 28.54 | 154,829 |
| 2024-12-02 | Pande Atul (Director) | Sale | 7,750 | 28.54 | 221,185 |
| 2024-11-20 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,174 | 25.45 | 106,228 |
| 2024-11-20 | Macias William L. (Chief Medical Officer) | Sale | 3,353 | 25.45 | 85,333 |
| 2024-11-20 | Salzmann Peter (Chief Executive Officer) | Sale | 16,692 | 25.45 | 424,811 |
| 2024-11-20 | Levine Mark S. (Chief Legal Officer) | Sale | 3,650 | 25.45 | 92,892 |
| 2024-10-23 | Geffner Michael (Chief Medical Officer) | Sale | 3,189 | 29.53 | 94,171 |
| 2024-10-23 | Stout Jay S (Chief Technology Officer) | Sale | 2,740 | 29.53 | 80,912 |
| 2024-10-23 | Levine Mark S. (Chief Legal Officer) | Sale | 4,361 | 29.53 | 128,780 |
| 2024-10-16 | Barnett Eva Renee (Chief Financial Officer) | Sale | 3,271 | 28.79 | 94,172 |
| 2024-10-16 | Macias William L. (Chief Medical Officer) | Sale | 3,188 | 28.79 | 91,782 |
| 2024-10-16 | Salzmann Peter (Chief Executive Officer) | Sale | 9,095 | 28.79 | 261,845 |
| 2024-10-16 | Levine Mark S. (Chief Legal Officer) | Sale | 2,860 | 28.79 | 82,339 |
| 2024-10-09 | Barnett Eva Renee (Chief Financial Officer) | Sale | 5,162 | 29.56 | 152,588 |
| 2024-10-09 | Salzmann Peter (Chief Executive Officer) | Sale | 4,460 | 29.56 | 131,837 |
| 2024-08-21 | Barnett Eva Renee (Chief Financial Officer) | Sale | 3,768 | 32.08 | 120,877 |
| 2024-08-21 | Macias William L. (Chief Medical Officer) | Sale | 3,027 | 32.08 | 97,106 |
| 2024-08-21 | Salzmann Peter (Chief Executive Officer) | Sale | 15,068 | 32.08 | 483,381 |
| 2024-08-21 | Butchko Julia G. (Chief Development Officer) | Sale | 3,027 | 32.08 | 97,106 |
| 2024-08-21 | Levine Mark S. (Chief Legal Officer) | Sale | 3,295 | 32.08 | 105,703 |
| 2024-07-24 | Geffner Michael (Chief Medical Officer) | Sale | 3,456 | 27.76 | 95,938 |
| 2024-07-24 | Stout Jay S (Chief Technology Officer) | Sale | 2,813 | 27.76 | 78,088 |
| 2024-07-24 | Levine Mark S. (Chief Legal Officer) | Sale | 4,015 | 27.76 | 111,456 |
| 2024-07-17 | Barnett Eva Renee (Chief Financial Officer) | Sale | 3,123 | 30.09 | 93,986 |
| 2024-07-17 | Macias William L. (Chief Medical Officer) | Sale | 3,044 | 30.09 | 91,609 |
| 2024-07-17 | Salzmann Peter (Chief Executive Officer) | Sale | 8,685 | 30.09 | 261,375 |
| 2024-07-17 | Butchko Julia G. (Chief Development Officer) | Sale | 2,867 | 30.09 | 86,282 |
| 2024-07-17 | Levine Mark S. (Chief Legal Officer) | Sale | 2,505 | 30.09 | 75,387 |
| 2024-07-09 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,747 | 28.06 | 133,200 |
| 2024-07-09 | Salzmann Peter (Chief Executive Officer) | Sale | 4,619 | 28.06 | 129,609 |
| 2024-07-09 | Butchko Julia G. (Chief Development Officer) | Sale | 1,527 | 28.06 | 42,847 |
| 2024-05-22 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,042 | 29.65 | 119,845 |
| 2024-05-22 | Macias William L. (Chief Medical Officer) | Sale | 3,247 | 29.65 | 96,273 |
| 2024-05-22 | Salzmann Peter (Chief Executive Officer) | Sale | 16,163 | 29.65 | 479,232 |
| 2024-05-22 | Butchko Julia G. (Chief Development Officer) | Sale | 3,247 | 29.65 | 96,273 |
| 2024-05-22 | Levine Mark S. (Chief Legal Officer) | Sale | 3,242 | 29.65 | 96,125 |
| 2024-04-24 | Geffner Michael (Chief Medical Officer) | Sale | 3,261 | 28.90 | 94,242 |
| 2024-04-24 | Stout Jay S (Chief Technology Officer) | Sale | 7,239 | 28.90 | 209,207 |
| 2024-04-24 | Levine Mark S. (Chief Legal Officer) | Sale | 3,963 | 28.90 | 114,530 |
| 2024-04-17 | Barnett Eva Renee (Chief Financial Officer) | Sale | 12,253 | 29.37 | 359,870 |
| 2024-04-17 | Macias William L. (Chief Medical Officer) | Sale | 8,280 | 29.37 | 243,183 |
| 2024-04-17 | Salzmann Peter (Chief Executive Officer) | Sale | 34,079 | 29.37 | 1,000,900 |
| 2024-04-17 | Butchko Julia G. (Chief Development Officer) | Sale | 10,115 | 29.37 | 297,077 |
| 2024-04-17 | Levine Mark S. (Chief Legal Officer) | Sale | 9,827 | 29.37 | 288,618 |
| 2024-04-09 | Barnett Eva Renee (Chief Financial Officer) | Sale | 3,689 | 31.18 | 115,023 |
| 2024-04-09 | Salzmann Peter (Chief Executive Officer) | Sale | 4,807 | 31.18 | 149,882 |
| 2024-04-09 | Butchko Julia G. (Chief Development Officer) | Sale | 1,053 | 31.18 | 32,832 |
| 2024-02-22 | Barnett Eva Renee (Chief Financial Officer) | Sale | 2,930 | 36.15 | 105,919 |
| 2024-02-22 | Macias William L. (Chief Medical Officer) | Sale | 2,221 | 36.15 | 80,289 |
| 2024-02-22 | Salzmann Peter (Chief Executive Officer) | Sale | 13,454 | 36.15 | 486,362 |
| 2024-02-22 | Butchko Julia G. (Chief Development Officer) | Sale | 2,146 | 36.15 | 77,577 |
| 2024-02-22 | Levine Mark S. (Chief Legal Officer) | Sale | 2,134 | 36.15 | 77,144 |
| 2024-01-26 | Geffner Michael (Chief Medical Officer) | Sale | 10,101 | 38.18 | 385,656 |
| 2024-01-26 | Levine Mark S. (Chief Legal Officer) | Sale | 3,027 | 38.18 | 115,570 |
| 2024-01-11 | Barnett Eva Renee (Chief Financial Officer) | Sale | 3,515 | 42.03 | 147,753 |
| 2024-01-05 | Salzmann Peter (Chief Executive Officer) | Sale | 3,824 | 38.59 | 147,568 |
| 2024-01-05 | Butchko Julia G. (Chief Development Officer) | Sale | 1,297 | 38.59 | 50,051 |
| 2023-12-01 | Pande Atul (Director) | Sale | 12,350 | 39.69 | 490,208 |
| 2023-12-01 | Fromkin Andrew J. (Director) | Sale | 12,350 | 39.68 | 490,085 |
| 2023-11-22 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,055 | 33.13 | 134,362 |
| 2023-11-22 | Macias William L. (Chief Medical Officer) | Sale | 3,265 | 33.13 | 108,185 |
| 2023-11-22 | Salzmann Peter (Chief Executive Officer) | Sale | 16,217 | 33.13 | 537,350 |
| 2023-11-22 | Butchko Julia G. (Chief Development Officer) | Sale | 3,265 | 33.13 | 108,185 |
| 2023-11-22 | Levine Mark S. (Chief Legal Officer) | Sale | 3,252 | 33.13 | 107,755 |
| 2023-10-25 | Levine Mark S. (Chief Legal Officer) | Sale | 4,107 | 34.66 | 142,348 |
| 2023-10-19 | Macias William L. (Chief Medical Officer) | Sale | 530 | 36.80 | 19,504 |
| 2023-10-10 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,557 | 36.92 | 168,244 |
| 2023-10-05 | Salzmann Peter (Chief Executive Officer) | Sale | 5,239 | 35.97 | 188,420 |
| 2023-10-05 | Butchko Julia G. (Chief Development Officer) | Sale | 1,735 | 35.97 | 62,399 |
| 2023-10-02 | Roivant Sciences Ltd. | Buy | 1,526,316 | 38.00 | 58,000,008 |
| 2023-08-30 | Salzmann Peter (Chief Executive Officer) | Sale | 56,774 | 22.23 | 1,261,802 |
| 2023-08-24 | Barnett Eva Renee (Chief Financial Officer) | Sale | 14,386 | 20.59 | 296,279 |
| 2023-08-24 | Macias William L. (Chief Medical Officer) | Sale | 12,333 | 20.59 | 253,998 |
| 2023-08-24 | Butchko Julia G. (Chief Development Officer) | Sale | 12,333 | 20.59 | 253,998 |
| 2023-08-24 | Levine Mark S. (Chief Legal Officer) | Sale | 12,286 | 20.59 | 253,030 |
| 2023-08-14 | Salzmann Peter (Chief Executive Officer) | Sale | 103,058 | 21.69 | 2,235,328 |
| 2023-08-07 | Salzmann Peter (Chief Executive Officer) | Sale | 101,339 | 21.73 | 2,202,096 |
| 2023-07-26 | Levine Mark S. (Chief Legal Officer) | Sale | 3,917 | 21.63 | 84,724 |
| 2023-07-19 | Barnett Eva Renee (Chief Financial Officer) | Sale | 2,725 | 24.94 | 67,961 |
| 2023-07-19 | Macias William L. (Chief Medical Officer) | Sale | 426 | 24.94 | 10,624 |
| 2023-07-12 | Salzmann Peter (Chief Executive Officer) | Sale | 3,233 | 19.73 | 63,787 |
| 2023-07-12 | Butchko Julia G. (Chief Development Officer) | Sale | 1,470 | 19.73 | 29,003 |
| 2023-04-25 | Macias William L. (Chief Medical Officer) | Sale | 509 | 16.29 | 8,291 |
| 2023-04-25 | Levine Mark S. (Chief Legal Officer) | Sale | 2,633 | 16.29 | 42,891 |
| 2023-04-18 | Barnett Eva Renee (Chief Financial Officer) | Sale | 3,423 | 15.27 | 52,269 |
| 2023-04-18 | Salzmann Peter (Chief Executive Officer) | Sale | 3,395 | 15.27 | 51,841 |
| 2023-04-18 | Butchko Julia G. (Chief Development Officer) | Sale | 1,544 | 15.27 | 23,576 |
| 2023-02-02 | Macias William L. (Chief Medical Officer) | Sale | 537 | 18.24 | 9,794 |
| 2023-01-26 | Levine Mark S. (Chief Legal Officer) | Sale | 10,156 | 18.51 | 187,987 |
| 2023-01-11 | Barnett Eva Renee (Chief Financial Officer) | Sale | 4,510 | 15.95 | 71,934 |
| 2023-01-11 | Macias William L. (Chief Medical Officer) | Sale | 44,568 | 15.93 | 709,968 |
| 2023-01-11 | Salzmann Peter (Chief Executive Officer) | Sale | 4,021 | 16.80 | 67,552 |
| 2023-01-11 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 60,490 | 15.97 | 966,327 |
| 2022-10-21 | Macias William L. (Chief Medical Officer) | Sale | 341 | 9.67 | 3,297 |
| 2022-10-13 | Salzmann Peter (Chief Executive Officer) | Sale | 2,793 | 9.18 | 25,639 |
| 2022-10-13 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 928 | 9.18 | 8,519 |
| 2022-10-11 | Barnett Eva Renee (Chief Financial Officer) | Sale | 12,500 | 9.44 | 118,000 |
| 2022-10-06 | Roivant Sciences Ltd. | Buy | 416,667 | 6.00 | 2,500,002 |
| 2022-09-29 | Torti Frank | Buy | 40,000 | 5.81 | 232,398 |
| 2022-09-28 | Salzmann Peter (Chief Executive Officer) | Sale | 1,605 | 4.67 | 7,495 |
| 2022-09-28 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 535 | 4.67 | 2,498 |
| 2022-08-30 | Salzmann Peter (Chief Executive Officer) | Sale | 1,644 | 5.83 | 9,584 |
| 2022-08-30 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 548 | 5.83 | 3,194 |
| 2022-07-27 | Salzmann Peter (Chief Executive Officer) | Sale | 1,528 | 4.27 | 6,524 |
| 2022-07-27 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 510 | 4.27 | 2,177 |
| 2022-07-22 | Macias William L. (Chief Medical Officer) | Sale | 322 | 4.70 | 1,513 |
| 2022-06-29 | Salzmann Peter (Chief Executive Officer) | Sale | 1,376 | 4.02 | 5,531 |
| 2022-06-29 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 460 | 4.02 | 1,849 |
| 2022-05-24 | Salzmann Peter (Chief Executive Officer) | Sale | 1,471 | 3.79 | 5,575 |
| 2022-05-24 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 492 | 3.79 | 1,864 |
| 2022-04-27 | Salzmann Peter (Chief Executive Officer) | Sale | 1,622 | 4.72 | 7,655 |
| 2022-04-27 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 541 | 4.72 | 2,553 |
| 2022-04-19 | Macias William L. (Chief Medical Officer) | Sale | 1,392 | 4.98 | 6,932 |
| 2022-03-24 | Salzmann Peter (Chief Executive Officer) | Sale | 19,227 | 5.90 | 113,439 |
| 2022-03-24 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 6,381 | 5.90 | 37,647 |
| 2022-01-07 | Barnett Eva Renee (Chief Financial Officer) | Sale | 29,959 | 7.25 | 217,202 |
| 2022-01-07 | Salzmann Peter (Chief Executive Officer) | Sale | 125,158 | 7.25 | 907,395 |
| 2022-01-07 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Sale | 55,318 | 7.25 | 401,055 |
| 2022-01-05 | Macias William L. (Chief Medical Officer) | Sale | 26,813 | 8.28 | 222,011 |
| 2021-08-27 | Hughes Douglas J. | Buy | 18,247 | 8.24 | 150,355 |
| 2021-08-20 | Migausky George V | Buy | 7,000 | 7.65 | 53,550 |
| 2021-08-13 | Pande Atul | Buy | 5,000 | 7.98 | 39,900 |
| 2021-08-10 | Fromkin Andrew J. | Buy | 5,500 | 7.90 | 43,450 |
| 2020-09-11 | Butchko Julia G. (Chief Dev. & Tech. Officer) | Buy | 5,000 | 38.17 | 190,850 |
| 2020-09-04 | Roivant Sciences Ltd. (10% Owner) | Buy | 380,000 | 33.00 | 12,540,000 |
| 2020-04-16 | Roivant Sciences Ltd. (10% Owner) | Buy | 1,034,483 | 14.50 | 15,000,003 |
| 2019-12-11 | Wong Roderick (Chief Executive Officer) | Buy | 31,500 | 10.92 | 344,011 |
| 2019-12-10 | Wong Roderick (Chief Executive Officer) | Buy | 25,971 | 10.38 | 269,527 |
| 2019-12-06 | Wong Roderick (Chief Executive Officer) | Buy | 450,000 | 10.23 | 4,610,149 |
| 2019-12-05 | Wong Roderick (Chief Executive Officer) | Buy | 20,000 | 10.15 | 203,000 |
| 2019-12-04 | Wong Roderick (Chief Executive Officer) | Buy | 20,000 | 10.15 | 203,000 |
| 2019-12-03 | Wong Roderick (Chief Executive Officer) | Buy | 20,000 | 10.21 | 204,200 |
| 2019-12-02 | Wong Roderick (Chief Executive Officer) | Buy | 20,000 | 10.40 | 208,000 |
| 2019-11-29 | Wong Roderick (Chief Executive Officer) | Buy | 26,918 | 10.45 | 281,293 |
| 2019-11-27 | Wong Roderick (Chief Executive Officer) | Buy | 4,000 | 10.48 | 41,904 |
| 2019-11-26 | Wong Roderick (Chief Executive Officer) | Buy | 4,000 | 10.49 | 41,960 |
| 2019-11-25 | Wong Roderick (Chief Executive Officer) | Buy | 4,000 | 10.50 | 42,000 |
| 2019-11-22 | Wong Roderick (Chief Executive Officer) | Buy | 2,000 | 10.54 | 21,080 |
| 2019-11-21 | Wong Roderick (Chief Executive Officer) | Buy | 15,194 | 10.42 | 158,306 |
| 2019-11-20 | Wong Roderick (Chief Executive Officer) | Buy | 29,805 | 10.39 | 309,584 |
| 2019-11-19 | Wong Roderick (Chief Executive Officer) | Buy | 29,805 | 10.25 | 305,501 |
| 2019-11-18 | Wong Roderick (Chief Executive Officer) | Buy | 29,805 | 10.25 | 305,501 |
| 2019-11-15 | Wong Roderick (Chief Executive Officer) | Buy | 13,000 | 10.29 | 133,796 |
| 2019-11-14 | Wong Roderick (Chief Executive Officer) | Buy | 13,000 | 10.17 | 132,210 |
| 2019-11-13 | Wong Roderick (Chief Executive Officer) | Buy | 13,000 | 10.17 | 132,210 |
| 2019-11-12 | Wong Roderick (Chief Executive Officer) | Buy | 100,000 | 10.17 | 1,017,000 |
| 2019-11-11 | Wong Roderick (Chief Executive Officer) | Buy | 13,000 | 10.18 | 132,340 |
| 2019-11-07 | Wong Roderick (Chief Executive Officer) | Buy | 17,500 | 10.18 | 178,150 |
Insider trading activities including stock purchases, stock sales, and option exercises
of IMVT listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Immunovant, Inc. (symbol IMVT,
CIK number 1764013) see
the Securities and Exchange Commission (SEC) website.